News

Business Wire3y
Vectorious Begins the VECTOR-HF II Study of its Implantable In-Heart Sensor for Left Atrial Pressure-Guided Patient Self-Management of Heart Failure - Business Wire
The results of the VECTOR-HF I study will be presented at the prestigious Late-Breaking Trials session during the European Society of Cardiology Heart Failure 2022 conference in Madrid, Spain ...
Business Wire3y
Vectorious Announces VECTOR-HF I Study Confirms Safety and Accuracy of V-LAP In-Heart Sensor for Left Atrial Pressure Management of Heart Failure - Business Wire
The VECTOR-HF I data was presented on May 22 during a prestigious late-breaking science forum at the European Society of Cardiology (ESC) Heart Failure 2022 and is the first clinical data from ...